Cryosurgical ablation of the normal ventral prostate plus adjuvant does not protect Copenhagen rats from dunning prostatic adenocarcinoma challenge

Journal of Urology

Volumn 158, Issue 4, 1997, Pages 1585-1588

  Friedman, Eric J ^a   Orth, Charles R ^a   Brewton, Kevin A ^a   Ponniah, Sathibalan ^a   Alexander, Richard B ^a  

^a VAMHCS ^*

Author keywords

Cryosurgery; Prostate; Prostatic neoplasms; Rat; Tumor immunology

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CONTROLLED STUDY; CRYOSURGERY; LAPAROTOMY; MALE; MELANOMA; NONHUMAN; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE VENTRAL LOBE; RAT;

EID: 0030864549     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)64284-8     Document Type: Article

References (26)

1. Gonder, M. J., Soanes, W. A. and Smith, V.: Experimental prostate cryosurgery. Invest. Urol., 1: 610, 1964.
2. Ablin, R. J.: Handbook of Cryosurgery. Marcel Dekker, Inc., New York, 1980.
3. Loening, S., Hawtrey, C., Bonney, W., Narayana, A. and Culp D.: Cryotherapy of prostate cancer. Prostate 1: 279, 1980.
4. Soanes, W. A , Ablin, R. J. and Gonder, M. J.: Remission of metastatic lesions following cryosurgery in prostatic cancer: immunologic considerations. J. Urol., 104: 154, 1970.
5. Gursel, E., Roberts, M. and Veenema, R. J.: Regression of prostatic cancer following sequential cryotherapy to the prostate. J. Urol., 108: 928, 1972.
6. Loening, S. and Lubaroff, D.: Cryosurgery and immunotherapy for prostatic cancer. Urol. Clin. North Am., 11: 327, 1984.
7. Ablin, R. J.: An appreciation and realization of the concept of cryoimmunology. In: Percutaneous Prostate Cryoablation. Edited by Onik, G. M. St. Louis: Quality Medical Publishing, pp. 136-154, 1995.
8. Blackwood, C. E. and Cooper, I. S.: Response of experimental tumor systems to cryosurgery. Cryobiology, 9: 508, 1972.
9. Faraci, R. P., Bagely, D. H., Marrone, J. and Beazley, R. M.: In vitro demonstration of cryosurgical augmentation of tumor immunity. Surgery, 77: 433, 1975.
10. Matsumura, K., Sakata, K., Saji, S., Misao, A. and Kunieda, T.: Antitumor immunologic reactivity in the relatively early period after cryosurgery: experimental studies in the rat. Cryobiology, 19: 263, 1982.
11. Bakker, A. B. H., Schreurs, M. J. W., DeBoer, A. J., Kawakami, Y., Rosenberg, S. A., Adema, G. J. and Figdor, C. G.: Melanocyte lineage-specific antigen gp100 is recognized by melanoma derived tumor infiltrating lymphocytes. J. Exp. Med., 179: 1005, 1994.
12. Kawakami, Y., Eliyahu, S., Delgado, C. H., Robbins, P. F., Sajaguchi, K., Appella, E., Yannelli, J. R., Adema, G. J., Miki, T. and Rosenberg, S. A.: Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc. Natl. Acad. Sci. USA, 91: 6458, 1994.
13. Visseren, M. J. W., van Elsas, A., van der Voort, E. I. H., Ressing, M. E., Kast, W. M., Schrier, P. I. and Melicf, C. J. M.: CTL specific for tyrosinase autoantigen can be induced from healthy donor blood to lyse melanoma cells. J. Immunol., 154: 3991, 1995.
14. Isaacs, J. T., Isaacs, W. B., Feitz, W. F. J. and Scheres, J.: Establishment and characterization of seven Dunning rat prostatic cancer cell lines and their use in developing methods for predicting metastatic abilities of prostatic cancers. Prostate, 9: 261, 1986.
15. Lubaroff, D. M., Reynolds, C. W., Canfield, L., McElligott, D. and Feldbush, T.: Immunologic aspects of the prostate. Prostate, 2: 233, 1981.
16. Lubaroff, D. M., Reynolds, C. W. and Culp, D. A.: Immunologic studies of prostatic cancer using the R3327 rat model. Transactions of the American Association of Genito-Urinary Surgeons, 70: 60, 1978.
17. Miya, K., Saji, S., Morita, T., Niwa, H., Takao, H., Kida, H. and Sakata, K.: Immunological response of regional lymph nodes after tumor cryosurgery: experimental study in rats. Cryobiology, 23: 290, 1986.
18. Hanawa, S.: An experimental study on the induction of antitumor immunological activity after cryosurgery for liver carcinoma, and the effect of concomitant immunotherapy with OK432. J. Japan Surg. Soc., 94: 57, 1993.
19. Yamashita, T., Hayakawa, K., Hosokawa, M., Kodama. T., Inoue, N., Tomita, K. and Kobayashi, H.: Enhanced tumor metastases in rats following cryosurgery of primary tumor. Gann, 73: 222, 1982.
20. Hayakawa, K., Yamashita, T., Suzuki, K., Tomita, K., Hosokawa, M., Kodama, T. and Kobayashi, H.: Comparative immunological studies in rats following cryosurgery and surgical excision of 3-methylcholanthrene-induced primary autochthonous tumors. Gann, 73: 462, 1982.
21. Melief, C. J. M. and Kast, W. M.: T-cell immunotherapy of cancer. Res. Immunol., 142: 425, 1991.
22. Melief, C. J. M. and Kast, W. M.: Prospects for T cell immunotherapy of tumours by vaccination with immunodominant and subdominant peptides. Ciba Foundation Symposium, 187: 97, 1994.
23. Taneja, S. S., Pang, S., Cohan, P. and Belldegrun, A.: Gene therapy: principles and potential. Cancer Surveys, 23: 247, 1995.
24. Nanda, N. K. and Sercarz, E. E.: Meeting review: induction of anti-self-immunity to cure cancer. Cell, 62: 13, 1995.
25. Houghton, A. N.: Cancer antigens: immune recognition of self and altered self. J. Exp. Med., 180: 1, 1994.
26. Toes, R. E. M., Blom, R. J. J., Offringa, R., Kast, W. M. and Melief, C. J. M.: Enhanced tumor outgrowth after peptide vaccination: functional deletion of tumor-specific CTL induced by peptide vaccination can lead to the inability to reject tumors. J. Immunol., 156: 3911, 1996.